Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies

Background: The tumor microenvironment and tumor immunity have become the focus of research on tumor diagnosis and treatment. Lymphocyte activation gene-3 (LAG-3, CD223) is a newly discovered immunosuppressive receptor that is abnormally expressed in various tumor microenvironments and plays an impo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yang, Wang, Wenwen, Tian, Jingluan, Zhou, Ying, Shen, Yu, Wang, Mingyuan, Tang, Longhai, Liu, Cuiping, Zhang, Xueguang, Shen, Fangrong, Chen, Youguo, Gu, Yanzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Novel Biomarkers, Molecular Diagnostics and Targeted Therapies of Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655791/
https://www.ncbi.nlm.nih.gov/pubmed/37968933
http://dx.doi.org/10.1177/15330338231202650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655791/
https://www.ncbi.nlm.nih.gov/pubmed/37968933
http://dx.doi.org/10.1177/15330338231202650

Ejemplares similares